Form 4 · Filed Jul 28, 2026, 08:15 PM UTC
ORIC/Oric Pharmaceuticals, Inc.
Heyman Richard A. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
4 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | M | other | 3,500 | $2 | $5,600 | 45,300 |
| Jul 24, 2026 | S | sell | 7,000 | $12 | $84,140 | 38,300 |
| Jul 24, 2026 | S | sell | 6,100 | $12 | $73,322 | 206,672 |
| Jul 24, 2026 | M | other | 3,500 | — | — | 30,200 |
Source: SEC EDGAR raw filing ↗ · Accession 0001584759-26-000015